Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × catumaxomab × Genitourinary × Clear all

NCT04819399 2022-04-05

Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC

Phase 1 Unknown

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms